Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
06 Setembro 2023 - 5:05PM
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative
medicine company focused on the development, manufacture, and
commercialization of product solutions for the Advanced Wound Care
and Surgical & Sports Medicine markets, today announced that
company management will participate in the Morgan Stanley 21st
Annual Global Healthcare Conference, which is being held at the
Sheraton New York Times Square Hotel in New York, NY from September
11th-13th. Management will host a fireside chat to discuss business
matters on Monday, September 11th at 8:00 a.m. Eastern Time.
A live audio webcast of the conference
presentation will be accessible by visiting the “Upcoming Events”
section on the “Investor Relations” page of Organogenesis’s website
www.organogenesis.com. An archive of the webcast will be available
for replay following the conference for approximately 30 days.
About Organogenesis Holdings
Inc.
Organogenesis Holdings Inc. is a leading
regenerative medicine company focused on the development,
manufacture and commercialization of solutions for the advanced
wound care and surgical and sports medicine markets. Organogenesis
offers a comprehensive portfolio of innovative regenerative
products to address patient needs across the continuum of care. For
more information, visit www.organogenesis.com.
Investor Inquiries:
ICR Westwicke
Mike Piccinino, CFA
OrganoIR@westwicke.com
Press and Media Inquiries:
Organogenesis
Ron O’Brien
communications@organo.com
Organogenesis (NASDAQ:ORGO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Organogenesis (NASDAQ:ORGO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024